Литература. 
Тиа

1. Ringleb P.A., Bousser M.-G., Ford G. et al. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008. Cerebrovasc Dis 2008; 25 (5): 457−507.

2. Rosamond W., Flegal K., Furie K. et al. Heart Disease and Stroke Statistics 2008 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25-e146.

3. Johnston S.C., Nguyen-Huynh M.N., Schwarz M.E. et al. National Stroke Association guidelines for the management of transient ischemic attacks. Annals of Neurology 2006; 60 (3): 301−313.

4. Ovbiagele B., Cruz-Flores S., Lynn M.J. et al.; Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Early stroke risk after transient ischemic attack among individuals with symptomatic intracranial artery stenosis. Arch Neurol 2008; 65 (6): 733−7.

5. Ovbiagele B., Kidwell C.S., Saver J.L. Epidemiological impact in the United States of a tissue-based definition of transient ischemic attack. Stroke 2003; 34: 919−924.

6. Ovbiagele B. Antiplatelet Therapy in Management of Transient Ischemic Attack: Overview and Evidence-Based Rationale. J Emerg Med 2008; 34 (4): 389−96.

7. Rothwell P.M., Giles M.F., Flossmann E. et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet 2005; 366 (9479): 29−36.

8. Rothwell P.M., Matthew F.G., Chandratheva A. et al.; on behalf of the Early use of Existing Preventive Strategies for Stroke (EXPRESS) study. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007; 370: 1432−42.

9. Lavallee P.C., Meseguer E., Abboud H. et al. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol 2007; 6 (11): 953−60.

10. Sacco R.L., Adams R., Albers G. et al. American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37: 577−617.

11. Adams R.J., Albers G., Alberts M.J. et al. Update to the AHA/ASA Recommendations for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. Stroke 2008; 39: 1647−1652.

12. Hankey G.J. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines. Current Medical Research and Opinion 2007; 23 (6): 1453−1462.

13. Verro P., Gorelick P.B., Nguyen D. Aspirin Plus Dipyridamole Versus Aspirin for Prevention of Vascular Events After Stroke or TIA. A MetaAnalysis. Stroke 2008; 39: 1358.